EAACI Congress 2025
BackFT03 - Urticaria and Angioedema
Friday 13 Jun, 13:15 PM -
14:45 PM Glasgow, United Kingdom
Dochart 2
Flash Talks
13:15
Sleep disturbance is a significant mediator between active disease and impaired work productivity in patients with chronic urticaria: Findings from a causal mediation analysis
13:22
Hidden parasitic causes in chronic spontaneous urticaria
13:29
IgE anti-TPO; from acute to chronic urticaria
13:36
The characteristics of Chronic Inducible Urticaria in Cape Town, South Africa
13:43
Impaired vascular autonomic control in HAE patients
13:50
Clinical Validation of a Novel Kinin Biomarker Assay for Characterisation of Bradykinin-Mediated Pathologies in US Subjects with Hereditary Angioedema
13:57
Demographic and diagnostic features of hereditary angioedema patients due to C1 inhibitor deficiency: a large cohort from the Italian network for hereditary and acquired angioedema (ITACA) Registry
14:04
Demographic, clinical, and genetic characterization of patients with hereditary angioedema due to mutation in coagulation factor XII in a population of southern Spain
14:11
Proactive identification of rare diseases: Lessons from hereditary angioedema diagnosis using electronic medical records
14:18
Characterization of pathomechanisms of acute and chronic spontaneous urticaria
14:25
Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Subanalysis of the Phase 3 OASIS-HAE Study
14:32
Real-World Evaluation of Omalizumab in Chronic Spontaneous and Inducible Urticaria: A Longitudinal Analysis during 15 years from a Lisbon UCARE
